logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
S

Statistics in Biopharmaceutical Research

IF1.3
Papers70
Citations
Journal Papers 70
Publication Date
delete
Challenges of Modeling Biomarker Effects on Time-to-Event Outcomes
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-07-03
delete0
PREAI
deleteWang, Tuo; Qu, Yongming
deleteShare
deleteSave
Bayesian Three-Parameter EMGE Survival Modeling with Hamiltonian Monte Carlo Methods
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-05-01
delete0
PREAI
deleteAkhtar, Md Tanwir
deleteShare
deleteSave
Extension and Application of the Partial Continual Reassessment Method to a Phase-IIa Dose-Finding Tuberculosis Trial with a Continuous Endpoint
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-05-01
delete0
PREAI
deleteSerra, Alessandra; Jaki, Thomas; Mozgunov, Pavel
deleteShare
deleteSave
Editor's Note
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-30
delete0
PREAI
deleteHe, Weili
deleteShare
deleteSave
Rejoinder - Statistical Methodology Groups in the Pharmaceutical Industry#
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-30
delete0
PREAI
deleteDevenport, Jenny; Mielke, Tobias; Akacha, Mouna; Rufibach, Kaspar; Ocampo, Alex; Lanius, Vivian; Vandemeulebroecke, Marc; Hougaard, Philip; Collin, Pierre; Wright, David; Hummel, Jurgen; Kunz, Cornelia Ursula; Krams, Mike
deleteShare
deleteSave
Commentary on "Statistical Methodology Groups in the Pharmaceutical Industry"
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-21
delete0
PREAI
deleteWang, Li; Yu, Binbing; Mo, May; Roychoudhury, Satrajit; Yu, Ron; Wang, Chenguang; Takeda, Kentaro
deleteShare
deleteSave
Commentary on the Manuscript "Statistical Methodology Groups in the Pharmaceutical Industry," by Davenport et al
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-19
delete0
PREAI
deletePinheiro (retired), Jose
deleteShare
deleteSave
Commentary on "Statistical Methodology Groups in the Pharmaceutical Industry"
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-11
delete1
PREAI
deleteSnapinn, Steven
deleteShare
deleteSave
Statistical Methodology Groups in the Pharmaceutical Industry#
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-04-09
delete1
PREAI
deleteDevenport, Jenny; Mielke, Tobias; Akacha, Mouna; Rufibach, Kaspar; Ocampo, Alex; Lanius, Vivian; Vandemeulebroecke, Marc; Hougaard, Philip; Collin, Pierre; Wright, David; Hummel, Jurgen; Kunz, Cornelia Ursula; Krams, Mike
deleteShare
deleteSave
6 Choose 4: A Framework to Understand and Facilitate Discussion of Strategies for Overall Survival Safety Monitoring
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete1
PREAI
deleteYung, Godwin; Rufibach, Kaspar; Wolbers, Marcel; Yan, Mark; Wang, Jue
deleteShare
deleteSave
Information Borrowing in Bayesian Clinical Trials: choice of Tuning Parameters for the Robust Mixture Prior
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteWeru, Vivienn; Kopp-Schneider, Annette; Wiesenfarth, Manuel; Weber, Sebastian; Calderazzo, Silvia
deleteShare
deleteSave
Estimating Treatment Efficacy Controlling for Subsequent Therapy Usage: Comparison of Multiple Methods and Application to Hematologic Oncology Trials
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteZheng, Cheng; Mishra-Kalyani, Pallavi; Norsworthy, Kelly J.; Sridhara, Rajeshwari; Logan, Brent R.
deleteShare
deleteSave
Statistical Efficiency of Model-Robust Direct Regression Adjustment in Randomized Clinical Trials with Binary Outcomes
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteHagiwara, Yasuhiro; Matsuyama, Yutaka
deleteShare
deleteSave
A Meta-Analysis Based Hierarchical Variance Model for Powering One and Two-Sample t-Tests
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteBarth, Jackson; Li, Ren-Cang; Wang, Xinlei
deleteShare
deleteSave
Bayesian Estimation of Dynamic Treatment Regimens in a Partially Randomized Patient Preference, Sequential, Multiple-Assignment, Randomized Trial
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteWank, Marianthie; Tamura, Roy N.; Braun, Thomas M.; Kidwell, Kelley M.
deleteShare
deleteSave
Multiplicity Control in Clinical Trials with Adaptive Selection Followed by Group-Sequential Testing
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-03-01
delete0
PREAI
deleteHua, Kaiyuan; Wang, Xiaofei; Luo, Xiaodong
deleteShare
deleteSave
Inverse Probability of Treatment Weighting: A Simple and Effective Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-02-01
delete0
PREAI
deleteShao, Yongwu; Zhang, Zhiwei; Ye, Zhishen
deleteShare
deleteSave
Mainstream Meta-Analysis of Clinical Trials Produces Strongly Inconsistent Estimators
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-02-01
delete0
PREAI
deleteShuster, Jonathan J.
deleteShare
deleteSave
Phase 2 Design Considerations from a Program Perspective
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-02-01
delete0
PREAI
deleteMielke, Tobias; Ohrn, Fredrik; Dragalin, Vladimir
deleteShare
deleteSave
A Bayesian Adaptive Marker-Stratified Design for Phase II Clinical Trials Using Calibrated Spike-and-Slab Priors
deleteStatistics in Biopharmaceutical Research
IF1.3
delete2026-02-01
delete0
PREAI
deleteShan, Mu; Lu, Mengyi; Han, Leng; Han, Yan; Zang, Yong
deleteShare
deleteSave